Lipocine To Present At The Raymond James Human Health Innovation Conference

SALT LAKE CITY, June 16, 2021 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will present at the Raymond James Human Health Innovation Conference. The conference will…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.